BioMarin Pharmaceutical
BMRN
#1909
Rank
โ‚ฌ8.80 B
Marketcap
45,81ย โ‚ฌ
Share price
-0.78%
Change (1 day)
-27.55%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ1.26 Billion

According to BioMarin Pharmaceutical's latest financial reports the company has โ‚ฌ1.26 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioMarin Pharmaceutical - Cash on Hand chart (from 1999 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ1.09 B12.55%
2023-12-31โ‚ฌ0.97 B-19.32%
2022-12-31โ‚ฌ1.20 B34.49%
2021-12-31โ‚ฌ0.89 B3.36%
2020-12-31โ‚ฌ0.86 B28.72%
2019-12-31โ‚ฌ0.67 B-29.01%
2018-12-31โ‚ฌ0.94 B-18.53%
2017-12-31โ‚ฌ1.16 B54.97%
2016-12-31โ‚ฌ0.75 B38.52%
2015-12-31โ‚ฌ0.54 B-30.26%
2014-12-31โ‚ฌ0.77 B36.77%
2013-12-31โ‚ฌ0.56 B67.85%
2012-12-31โ‚ฌ0.33 B125.35%
2011-12-31โ‚ฌ0.15 B-27.1%
2010-12-31โ‚ฌ0.20 B-1.8%
2009-12-31โ‚ฌ0.20 B-47.59%
2008-12-31โ‚ฌ0.40 B-0.16%
2007-12-31โ‚ฌ0.40 B83.21%
2006-12-31โ‚ฌ0.21 B442.59%
2005-12-31โ‚ฌ40.34 M12.11%
2004-12-31โ‚ฌ35.98 M-78.04%
2003-12-31โ‚ฌ0.16 B131.61%
2002-12-31โ‚ฌ70.76 M-52.33%
2001-12-31โ‚ฌ0.14 B247.86%
2000-12-31โ‚ฌ42.67 M-31.82%
1999-12-31โ‚ฌ62.59 M690.19%
1998-12-31โ‚ฌ7.92 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚ฌ0.36 B-71.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ25.4 M-98.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ79.31 M-93.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ8.96 B 607.24%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
โ‚ฌ0.22 B-82.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚ฌ0.59 B-53.32%๐Ÿ‡บ๐Ÿ‡ธ USA